1 rich Libsyn https://www.libsyn.com 300 600 A fascinating Lancet RCT shows once-weekly semaglutide may redefine alcohol use disorder treatment. 🎯 &amp;nbsp; In 108 adults with AUD and obesity, semaglutide reduced heavy drinking days by –13.7 percentage points vs placebo (p=0.0015) and improved craving, consumption, and biomarkers. 📉 &amp;nbsp; With an NNT of ~4.3 and a manageable safety profile, GLP-1 therapy signals a shift from abstinence to precision harm reduction. 💡 &amp;nbsp; Efficacy. Safety. Meaningful impact. &amp;nbsp; Is this the beginning of a new era in addiction medicine? 🧠💉 Dr. RR Baliga's 'Podkast for the Kurious Doc' http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41149735/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/201552630